NGL Fine-Chem Limited Reports Un-Audited Earnings Results for the Third Quarter and Nine Months Ended December 31, 2017
January 30, 2018 at 06:43 pm IST
Share
NGL Fine-Chem Limited reported un-audited earnings results for the third quarter and nine months ended December 31, 2017. For the quarter, the company reported net sales /income from operations of INR 292.7 million compared to INR 250.65 million, profit before exceptional items and tax of INR 33.1 million compared to INR 63.5 million, net profit before tax of INR 33.1 million compared to INR 63.5 million and profit after tax of INR 25.8 million or INR 4.26 per basic and diluted share compared to INR 42.1 million or INR 6.84 per basic and diluted share for the last year.
For the nine months, the company reported net sales /income from operations of INR 794.4 million compared to INR 706.2 million, profit before exceptional items and tax of INR 108.3 million compared to INR 171.9 million, net profit before tax of INR 108.3 million compared to INR 171.9 million and profit after tax of INR 78.9 million or INR 12.82 per basic and diluted share compared to INR 113.0 million or INR 18.39 per basic and diluted share for the last year.
NGL Fine-Chem Limited is an India-based company, which is a manufacturer of pharmaceuticals and intermediates for use in veterinary and human health. The Company caters to various global companies to custom manufacture pharmaceuticals. Its products include APIs Animal Health, APIs Human Health, Intermediates and Specialty Chemicals and Finished Dosage Form. The APIs Animal Health products include Homidium Chloride, Nitroxynil, Clorsulon, Parvaquone, Buparvaquone, Isometamidium Chloride Hydrochloride, Toldimfos Sodium, Butaphosphan, Imidocarb Dipropionate, Triclabendazole, Rafoxanide, Diminazene Aceturate, S-Methoprene, Carprofen and others. The APIs Human Health products include Nitazoxanide and Atovaquone. The Intermediates and Specialty Chemicals product includes 1,4,7-Trimethyl-1,4,7-Triazacylononane and N-Ethyl Glucamine. The Finished Dosage Form products include Diminazene Aceturate Granules and Homidium Chloride Tablets. It has manufacturing plants located around Mumbai.
NGL FINE-CHEM LIMITED 
